Skin sensitivity: an emerging signal Skin burning and abnormal touch sensitivity (dysesthesia) appears as a dose-related, reversible signal in two case series and post-market surveillance. Trials did not pre-specify it, and the tirzepatide label does not list it
Further, several VABS-II domain scores such as adaptive behavior ( p = 0.03), socialization ( p = 0.03), maladaptive behavior ( p = 0.04) and internalizing behavior ( p = 0.02) also indicated significant changes
However, HGH therapy is not without its risks, including the potential for joint pain, swelling, and a higher risk of diabetes, as noted in a study of elderly individuals [3]
It is an experimental compound not approved for human clinical use
Comparative Effectiveness While direct comparison studies are limited, BPC-157 has shown favorable results when evaluated against other regenerative approaches